These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 16373605

  • 1. Transforming growth factor beta 1 induces neointima formation through plasminogen activator inhibitor-1-dependent pathways.
    Otsuka G, Agah R, Frutkin AD, Wight TN, Dichek DA.
    Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):737-43. PubMed ID: 16373605
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Transcriptional regulation of plasminogen activator inhibitor-1 by transforming growth factor-beta, activin A and microphthalmia-associated transcription factor.
    Murakami M, Ikeda T, Saito T, Ogawa K, Nishino Y, Nakaya K, Funaba M.
    Cell Signal; 2006 Feb; 18(2):256-65. PubMed ID: 15961275
    [Abstract] [Full Text] [Related]

  • 5. Intimal hyperplasia and expression of transforming growth factor-beta1 in saphenous veins and internal mammary arteries before coronary artery surgery.
    Friedl R, Li J, Schumacher B, Hanke H, Waltenberger J, Hannekum A, Stracke S.
    Ann Thorac Surg; 2004 Oct; 78(4):1312-8. PubMed ID: 15464491
    [Abstract] [Full Text] [Related]

  • 6. Positive feedback loop between plasminogen activator inhibitor-1 and transforming growth factor-beta1 during renal fibrosis in diabetes.
    Seo JY, Park J, Yu MR, Kim YS, Ha H, Lee HB.
    Am J Nephrol; 2009 Oct; 30(6):481-90. PubMed ID: 19786738
    [Abstract] [Full Text] [Related]

  • 7. Growth state-dependent regulation of plasminogen activator inhibitor type-1 gene expression during epithelial cell stimulation by serum and transforming growth factor-beta1.
    Boehm JR, Kutz SM, Sage EH, Staiano-Coico L, Higgins PJ.
    J Cell Physiol; 1999 Oct; 181(1):96-106. PubMed ID: 10457357
    [Abstract] [Full Text] [Related]

  • 8. Defective processing of the transforming growth factor-beta1 in azoxymethane-induced mouse colon tumors.
    Guda K, Claffey KP, Dong M, Nambiar PR, Rosenberg DW.
    Mol Carcinog; 2003 May; 37(1):51-9. PubMed ID: 12720300
    [Abstract] [Full Text] [Related]

  • 9. TGF-beta 1-induced PAI-1 expression is E box/USF-dependent and requires EGFR signaling.
    Kutz SM, Higgins CE, Samarakoon R, Higgins SP, Allen RR, Qi L, Higgins PJ.
    Exp Cell Res; 2006 Apr 15; 312(7):1093-105. PubMed ID: 16457817
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Expression of transforming growth factor-beta1 (TGF-beta1) and urokinase-type plasminogen activator (u-PA) genes during arterial repair in the pig.
    Wysocki SJ, Zheng MH, Fan Y, Lamawansa MD, House AK, Norman PE.
    Cardiovasc Res; 1996 Jan 15; 31(1):28-36. PubMed ID: 8849586
    [Abstract] [Full Text] [Related]

  • 12. Adenovirus-mediated gene transfer of transforming growth factor-beta3, but not transforming growth factor-beta1, inhibits constrictive remodeling and reduces luminal loss after coronary angioplasty.
    Kingston PA, Sinha S, Appleby CE, David A, Verakis T, Castro MG, Lowenstein PR, Heagerty AM.
    Circulation; 2003 Dec 02; 108(22):2819-25. PubMed ID: 14638551
    [Abstract] [Full Text] [Related]

  • 13. A kunitz-type protease inhibitor bikunin disrupts ligand-induced oligomerization of receptors for transforming growth factor (TGF)-beta and subsequently suppresses TGF-beta signalings.
    Yagyu T, Kobayashi H, Wakahara K, Matsuzaki H, Kondo T, Kurita N, Sekino H, Inagaki K, Suzuki M, Kanayama N, Terao T.
    FEBS Lett; 2004 Oct 22; 576(3):408-16. PubMed ID: 15498571
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Plasminogen activator inhibitor-I-related regulation of procollagen I (alpha1 and alpha2) by antitransforming growth factor-beta1 treatment during radiation-impaired wound healing.
    Schultze-Mosgau S, Kopp J, Thorwarth M, Rödel F, Melnychenko I, Grabenbauer GG, Amann K, Wehrhan F.
    Int J Radiat Oncol Biol Phys; 2006 Jan 01; 64(1):280-8. PubMed ID: 16377416
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prevention of radiation-induced pneumonitis by recombinant adenovirus-mediated transferring of soluble TGF-beta type II receptor gene.
    Haiping Z, Takayama K, Uchino J, Harada A, Adachi Y, Kura S, Caicun Z, Tsuzuki T, Nakanishi Y.
    Cancer Gene Ther; 2006 Sep 01; 13(9):864-72. PubMed ID: 16710346
    [Abstract] [Full Text] [Related]

  • 20. Effects of pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 in radiation-induced intestinal injury.
    Abderrahmani R, François A, Buard V, Benderitter M, Sabourin JC, Crandall DL, Milliat F.
    Int J Radiat Oncol Biol Phys; 2009 Jul 01; 74(3):942-8. PubMed ID: 19480973
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.